Post-Stroke Cognitive Impairment Assessment and Management

Post-stroke cognitive impairment encompasses a spectrum of deficits in memory, attention, executive function and visuospatial abilities that arise following an ischaemic or haemorrhagic cerebrovascular event. It affects up to half of survivors and represents a major determinant of long‐term disability, reduced quality of life and increased care dependency. Early identification of cognitive deficits is critical: brief bedside instruments allow stratification of risk, guide individualised rehabilitation plans and inform secondary prevention strategies. Assessment spans acute screening in the first two weeks to comprehensive neuropsychological evaluation at six months and beyond, employing both general-purpose tests and domain‐specific batteries. Management combines optimisation of vascular risk factors, lifestyle modification, cognitive rehabilitation, psychosocial support and, where evidence supports, targeted pharmacotherapy. Integrated care pathways and risk-stratification tools direct timely interventions, while consensus guidelines highlight gaps in evidence for routine pharmacological treatments and call for rigorous trials of cognitive training and multi‐component interventions.

Research from Nature Portfolio

Investigators have developed and validated a clinical risk score that quantifies the likelihood of delayed post‐stroke cognitive impairment up to 18 months after an ischaemic event. The score integrates readily available data—age, initial stroke severity, lesion location, prior cerebrovascular history and neuroimaging features—to yield categories of low, medium and high risk. Across multiple cohorts in Asia, the model achieved robust discrimination, with area under the curve values between 0.74 and 0.82. Application of this tool at bedside can inform follow‐up intensity, prompt early rehabilitation referrals and support patient and caregiver counselling.

Post-Stroke Cognitive Impairment Assessment and Management publication trend

The graph below shows the total number of articles in post-stroke cognitive impairment assessment and management across all publications each year (not limited to Nature Index journals).

Technical terms

Post‐stroke cognitive impairment (PSCI): A decline in one or more cognitive domains attributable to a cerebrovascular event.

Oxford Cognitive Screen (OCS): A stroke‐specific tool that profiles domain‐specific deficits in language, praxis, memory and attention.

Montreal Cognitive Assessment (MoCA): A brief instrument for global cognitive screening sensitive to mild impairment.

Machine learning algorithms: Computational models that learn patterns from multidimensional data to predict individual outcomes.

Risk score: A composite clinical metric derived from patient characteristics and investigations to stratify likelihood of future events.

References

1. Domain-specific cognitive impairment 6 months after stroke: The value of early cognitive screening. International Journal of Stroke (2023).
2. Prediction of post-stroke cognitive impairment after acute ischemic stroke using machine learning. Alzheimer's Research & Therapy (2023).
3. Domain-specific versus generalized cognitive screening in acute stroke. Journal of Neurology (2015).
4. European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. European Stroke Journal (2021).
5. Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke. Scientific Reports (2017).